4//SEC Filing
KOSKI FAMILY LP 4
Accession 0000899243-18-018147
CIK 0001174940other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:32 PM ET
Size
17.2 KB
Accession
0000899243-18-018147
Insider Transaction Report
Form 4
ORAGENICS INCOGEN
KOSKI FAMILY LP
10% Owner
Transactions
- Award
Common Stock
2018-06-22+4,000→ 108,789 total - Award
Non-Employee Director Option (Right to Buy)
2018-06-22+14,000→ 14,000 totalExercise: $1.52From: 2019-06-22Exp: 2028-06-22→ Common Stock (14,000 underlying)
Holdings
- 2,800(indirect: By Koski Management, Inc.)
Common Stock
- 91,967
Common Stock
- 1,286,483
Common Stock
- 157,254
Common Stock
- 53,086(indirect: By Trust)
Common Stock
Footnotes (9)
- [F1]Shares owned directly by Koski Family Limited Partnership ("KFLP"). Shares owned indirectly by the KFLP general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
- [F2]Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
- [F3]Shares owned directly by Christine L. Koski.
- [F4]Shares owned directly by Robert C. Koski, a director of the Company.
- [F5]Shares owned directly by Thomas L. Koski.
- [F6]Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).
- [F7]Shares owned by trusts of which Mr. Robert C. Koski is sole trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (10,760 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (10,760 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (10,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (10,760 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (10,806 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.
- [F8]Represents an award of restricted stock in connection with service to the Company as a director pursuant to the 2012 Equity Incentive Plan that vests immediately.
- [F9]Represents an award of options to purchase shares of the Company's common stock under the Company's 2012 Equity Incentive Plan in connection with service to the Company as a director. The options vest one year from the grant date. The option exercise price is the closing price on the date of the grant, June 22, 2018.
Documents
Issuer
ORAGENICS INC
CIK 0001174940
Entity typeother
Related Parties
1- filerCIK 0001234879
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 4:32 PM ET
- Size
- 17.2 KB